MoneyWorks4Me

Lupin - Quaterly Results

06 May 2024 Evaluate
The revenue for the March 2024 quarter is pegged at Rs. 33958.80 millions, about 19.73% up against Rs. 28362.70 millions recorded during the year-ago period.The Net Profit of the company reported a remarkable increase of 222.73% to Rs. 3840.80  millions  from Rs. 1190.10 millions in previous same quarter.Operating profit for the quarter ended March 2024 rose to 7316.90 millions as compared to 3174.80 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 33958.80 28362.70 19.73 146665.00 112588.30 30.27 146665.00 112588.30 30.27
Other Income 313.40 553.00 -43.33 1067.30 912.60 16.95 1067.30 912.60 16.95
PBIDT 7316.90 3174.80 130.47 35657.90 11739.20 203.75 35657.90 11739.20 203.75
Interest 134.90 294.40 -54.18 563.50 984.40 -42.76 563.50 984.40 -42.76
PBDT 7182.00 2880.40 149.34 35094.40 10754.80 226.31 35094.40 10754.80 226.31
Depreciation 2900.40 1462.00 98.39 7247.50 5483.40 32.17 7247.50 5483.40 32.17
PBT 4281.60 1418.40 201.86 27846.90 5271.40 428.26 27846.90 5271.40 428.26
TAX 440.80 228.30 93.08 4586.00 1019.30 349.92 4586.00 1019.30 349.92
Deferred Tax -249.80 -25.90 864.48 -254.50 60.40 -521.36 -254.50 60.40 -521.36
PAT 3840.80 1190.10 222.73 23260.90 4252.10 447.04 23260.90 4252.10 447.04
Equity 911.40 910.00 0.15 911.40 910.00 0.15 911.40 910.00 0.15
PBIDTM(%) 21.55 11.19 92.49 24.31 10.43 133.18 24.31 10.43 133.18
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..